Update Myokarditis
暂无分享,去创建一个
S. Felix | M. Dörr | S. Könemann | D. Beug
[1] T. Lüscher,et al. Clinical Presentation and Laboratory Findings in Men Versus Women with Myocarditis. , 2020, Journal of Women's Health.
[2] J. Afilalo,et al. Diagnostic and prognostic value of cardiac magnetic resonance in acute myocarditis: a systematic review and meta-analysis , 2019, The International Journal of Cardiovascular Imaging.
[3] J. Banner,et al. Sudden cardiac death caused by myocarditis in persons aged 1–49 years: a nationwide study of 14 294 deaths in Denmark , 2019, Forensic sciences research.
[4] R. Manka,et al. Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study. , 2019, Swiss medical weekly.
[5] S. Iliceto,et al. How to improve therapy in myocarditis: role of cardiovascular magnetic resonance and of endomyocardial biopsy , 2019, European heart journal supplements : journal of the European Society of Cardiology.
[6] H. Heidbuchel,et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). , 2018, European heart journal.
[7] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.
[8] R. Manka,et al. Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up , 2017, Circulation. Heart failure.
[9] U. Eriksson,et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease , 2017, European heart journal.
[10] M. Sheppard,et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology , 2017, Virchows Archiv.
[11] S. Iliceto,et al. Myocarditis: A Clinical Overview , 2017, Current Cardiology Reports.
[12] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[13] S. Iliceto,et al. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management , 2013, Heart Failure Reviews.
[14] L. Cooper,et al. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. , 2011, Journal of the American College of Cardiology.
[15] M. Schieber,et al. Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.
[16] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[17] R. Holubkov,et al. Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.
[18] G. Berry,et al. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.